Replies to post #32854 on Titan Medical Inc (TMDIF)

[pontiacg6]

2011 Titan Medical Operational Highlights

TORONTO, ONTARIO--(Marketwire – August 16, 2011) – Titan Medical Inc. ("Titan” or the “Company") (TSX VENTURE: TMD) announced today results for the three and six months ended June 30, 2011. The financial statements and Management’s Discussion and Analysis for the period may be viewed on SEDAR.
Craig Leon, Chief Executive Officer of Titan Medical Inc., said, “The momentum created in the first quarter has carried over into the second quarter and we are very proud of our accomplishments to date. We established several industry leading relationships, including Crouse Hospital, Mayo Clinic and Sense Graphics, which enable us to proceed with development and testing of Amadeus ComposerTM. We also successfully raised $9.2 million, which provides us with sufficient funds to continue development of our next generation robotic surgical system during the second half of 2011.”
Operational Highlights
• Entered into an exclusive patent license agreement with Mayo Foundation for Medical Education and Research for its novel surgical stapler.
• Signed a development agreement with D&D Video Specialists, Inc. (D2 VideoTM), a leading developer of endoscopic vision systems. D2 VideoTM will design and develop a proprietary vision system for Amadeus ComposerTM.
• Appointed Dr. John R. Valvo, M.D., F.A.C.S. as Vice President of Medical Affairs.
• Appointed Dr. Carlo Camargo Passerotti, M.D., PhD and Dr. Li-Ming Su, M.D. to the Company's Medical Advisory Board.
• Signed a non-binding memorandum of understanding with Crouse Hospital, Inc., a 506-bed acute care hospital in Syracuse, NY. Crouse Hospital will test and evaluate Amadeus Composer TM.
• Announced positive testing results for its Beta Console early user study.
• Signed a development agreement with Proven Process Medical Devices, Inc. ("Proven Process"), a leading provider of medical device contract research and development, and manufacturing services. Proven Process will develop certain proprietary components of Amadeus Composer TM.

[cptjsd]

Agreed. I am going to see how the conferences play out and if it doesn't work out well then I am finally going to sell and take a huge loss. I have had no confidence in management for years but have been hanging on and giving them the benefit of the doubt. They keep proving me wrong. We have never been so close but if these conferences don't pan out then there will be more immediate dilution before June which will pull us down to the 30-40 cent range and that will be next to impossible to rebound from...the future high price warrants will all expire because they will be raising peanuts at peanut prices. It's a domino effect. Great product but crappy management and crappy timing. The $70 million from warrants is gone at this point., especially with a 60 million market cap..try to raise another $60 million at a these prices and see what that does to the share price. Great job management, Bertner, friends and family on the payroll. I think we are all screwed.

[RockoTaco]

Baloney

[Honeycomb777]

We will soon find the consensus on SPORT from SAGES.

** Either we are in trouble or warmly accepted. If the latter happens, then investor demand will start to happen and PPS goes UP.

They have already been out to Utah and AORN gets even more eyes on it. We will know soon IMO


Ximedica seems happy and they even wore cool sunglasses !!